It shares many molecular similarities with sporadic colorectal cancer, and preclinical investigators have demonstrated the potential role of Nrf2/Nuclear Factor kB (NF-κB) alterations even in the first stages of cancer occurrence [10,13,14]. This evidence concerns the gene NFE2L2 and cancer.